Sincalide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09142 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | malignant catarrh | KG + DL |
| 2 | infectious bovine rhinotracheitis | KG + DL |
| 3 | cytomegalovirus infection | KG + DL |
| 4 | thrombotic disease | KG + DL |
| 5 | hyperthyroidism | KG + DL |
| 6 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 7 | hyperthyroxinemia | KG + DL |
| 8 | homozygous familial hypercholesterolemia | KG + DL |
| 9 | Prinzmetal angina | KG + DL |
| 10 | amenorrhea (disease) | KG + DL |
| 11 | antithrombin deficiency type 2 | KG + DL |
| 12 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 13 | heparin cofactor 2 deficiency | KG + DL |
| 14 | conjunctivitis | KG + DL |
| 15 | conjunctivitis (disease) | KG + DL |
| 16 | roseolovirus infectious disease | KG + DL |
| 17 | multiple endocrine neoplasia | KG + DL |
| 18 | thrombophilia | KG + DL |
| 19 | non-inflammatory vasculopathy | KG + DL |
| 20 | drug-induced osteoporosis | KG + DL |
| 21 | vein disease | KG + DL |
| 22 | severe nonproliferative diabetic retinopathy | KG + DL |
| 23 | angiodysplasia | KG + DL |
| 24 | exanthem (disease) | KG + DL |
| 25 | Graves disease | KG + DL |
| 26 | fibrocartilaginous embolism | KG + DL |
| 27 | venous thromboembolism | KG + DL |
| 28 | hypoalphalipoproteinemia | KG + DL |
| 29 | congenital renal artery stenosis | KG + DL |
| 30 | postmenopausal osteoporosis | KG + DL |
| 31 | HIV infectious disease | KG + DL |
| 32 | pregnancy associated osteoporosis | KG + DL |
| 33 | diabetic retinopathy | KG + DL |
| 34 | psoriasis | KG + DL |
| 35 | neonatal thyrotoxicosis | KG + DL |
| 36 | acne (disease) | KG + DL |
| 37 | optic papillitis | KG + DL |
| 38 | eye disease | KG + DL |
| 39 | cavernous sinus thrombosis | KG + DL |
| 40 | lateral sinus thrombosis | KG + DL |
| 41 | Worth syndrome | KG + DL |
| 42 | feline acquired immunodeficiency syndrome | KG + DL |
| 43 | simian immunodeficiency virus infection | KG + DL |
| 44 | von Hippel anomaly | KG + DL |
| 45 | arterial calcification of infancy | KG + DL |
| 46 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 47 | osteogenesis imperfecta with opalescent teeth, blue sclerae and wormian bones but without fractures | KG + DL |
| 48 | vascular ectasia | KG + DL |
| 49 | lagophthalmos | KG + DL |
| 50 | atrial fibrillation (disease) | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.